Type 1 diabetes is caused by the immune system mistakenly attacking and destroying the insulin-producing cells in the pancreas. These cells, called beta cells, are the body’s only source of insulin, the hormone that moves sugar from your blood into your cells for energy. Once enough beta cells are destroyed, the body can no longer regulate blood sugar, and type 1 diabetes develops. Unlike type 2 diabetes, which involves the body becoming resistant to insulin, type 1 is an autoimmune disease where the immune system itself is the problem.
What triggers this immune attack isn’t one single thing. It’s a combination of genetic vulnerability and environmental factors that, together, set the process in motion.
The Autoimmune Process Behind It
In a healthy immune system, white blood cells identify and attack foreign invaders like bacteria and viruses while leaving the body’s own tissues alone. In type 1 diabetes, something goes wrong with this recognition system. The immune system begins treating beta cells as threats, producing specialized proteins called autoantibodies that target them. Over time, these attacks gradually reduce the number of functioning beta cells in the pancreas.
This destruction doesn’t happen overnight. The autoimmune process can quietly unfold over months or even years before any symptoms appear. By the time someone is diagnosed with type 1 diabetes, a significant portion of their beta cells has already been lost. That slow, silent progression is why researchers now describe type 1 diabetes in three stages, which we’ll cover below.
Genetics Load the Gun
Type 1 diabetes runs in families, but not in a straightforward way. It isn’t caused by a single gene. Instead, certain variations in a group of immune-system genes (known as HLA genes) make a person more susceptible to the autoimmune process. These genes help the immune system distinguish the body’s own cells from foreign invaders. When specific variations are present, the immune system is more likely to misidentify beta cells as threats.
Twin studies illustrate just how significant genetics are, and also how much they don’t explain on their own. Among identical twins (who share 100% of their DNA), if one twin has type 1 diabetes and the other tests positive for autoantibodies at screening, the second twin has a 69% chance of developing diabetes within three years. But if the second twin is autoantibody-negative, that risk drops to just 1.5%. Identical twins are also far more likely to develop autoantibodies than non-identical twins or other siblings. This tells us genetics create vulnerability, but something else has to flip the switch.
Environmental Triggers Pull It
Researchers have investigated several environmental factors that may activate the autoimmune process in genetically susceptible people. No single trigger has been definitively proven, but the strongest evidence points to viral infections.
Viral Infections
Enteroviruses, particularly a group called Coxsackieviruses, are the most frequently linked viral suspects. As far back as 1969, researchers noticed that people recently diagnosed with type 1 diabetes tended to have higher levels of Coxsackievirus antibodies in their blood than people with long-established diabetes or healthy individuals. Since then, a growing body of research has strengthened this connection. The leading theory is that Coxsackieviruses can persistently infect the insulin-producing cells of the pancreas, triggering a localized immune overreaction that damages those cells. Other viruses, including mumps and congenital rubella, have also been linked to type 1 diabetes in epidemiological studies, though Coxsackieviruses remain the most commonly implicated.
It’s worth noting that a definitive causal link between any specific virus and type 1 diabetes hasn’t been established in humans. What exists is a significant and growing body of positive correlations.
Gut Bacteria and Early Immune Development
The community of bacteria living in your gut plays a major role in training the immune system during early life. Disruptions to this bacterial ecosystem, sometimes called dysbiosis, have gained attention as a possible contributing factor. Changes in gut bacteria composition appear to occur before the autoantibodies associated with type 1 diabetes even show up, suggesting these shifts may be part of what sets the autoimmune process in motion rather than a consequence of it. Animal studies have shown that giving antibiotics to young rodents (which disrupts their gut bacteria) can accelerate the onset of type 1 diabetes.
This connects to the broader “hygiene hypothesis,” which suggests that children raised in overly clean environments with fewer microbial exposures may have immune systems that are more prone to attacking the body’s own tissues. The worldwide rise in type 1 diabetes incidence, particularly in developed countries, lends some support to this idea, though it remains an area of active investigation.
Vitamin D
Vitamin D plays a role in immune regulation, and some studies have found that children with type 1 diabetes tend to have lower vitamin D levels. In lab settings, vitamin D acts as an immune modulator, reducing the activity of immune cells involved in autoimmune attacks. However, when researchers pooled multiple studies together, vitamin D supplementation did not significantly reduce the odds of developing type 1 diabetes or developing the autoantibodies that precede it. The connection between low vitamin D and type 1 diabetes may reflect other factors (like spending less time outdoors or socioeconomic differences) rather than a direct cause.
Cow’s Milk Formula
For years, there was debate about whether feeding infants cow’s milk-based formula might increase their risk of type 1 diabetes. A 15-year global study of over 2,100 infants who were genetically predisposed to the disease put this question to rest. Researchers compared infants who received conventional cow’s milk formula with those who received a formula where the milk proteins were broken into smaller pieces. The rates of type 1 diabetes were virtually identical: 7.6% in the conventional formula group and 8.4% in the modified formula group. There is no evidence that cow’s milk formula increases type 1 diabetes risk.
The Three Stages of Type 1 Diabetes
Because the autoimmune process unfolds gradually, researchers now classify type 1 diabetes into three stages. This framework helps identify people who are on the path to diagnosis before they ever feel sick.
Stage 1: The immune system has begun its attack. Blood tests reveal two or more diabetes-related autoantibodies, but blood sugar levels are still completely normal. There are no symptoms. A person at this stage would have no idea anything was happening without specific screening.
Stage 2: The ongoing destruction of beta cells has progressed enough that blood sugar levels start to become abnormal, though still not high enough for a traditional diabetes diagnosis. Autoantibodies are still present, and there are still no noticeable symptoms. This stage can last for varying lengths of time.
Stage 3: This is the point of clinical diagnosis. Enough beta cells have been destroyed that the body can no longer maintain blood sugar control. Symptoms appear: excessive thirst, frequent urination, unexplained weight loss, fatigue, and blurry vision. This is when most people first learn they have type 1 diabetes.
Screening programs can now identify people at stage 1 or 2, which is valuable because it eliminates the risk of a dangerous emergency at diagnosis (called diabetic ketoacidosis) and opens the door to treatments that may slow the progression from stage 2 to stage 3.
How Autoantibodies Confirm the Diagnosis
When doctors suspect type 1 diabetes, they test for specific autoantibodies in the blood. The three most important ones target proteins found on or inside beta cells: GAD65, IA-2, and ZnT8. Each of these autoantibodies is independently associated with insulin deficiency in young people with diabetes, which means testing for all three gives a more complete picture than testing for just one. The presence of two or more autoantibodies is what distinguishes type 1 diabetes from type 2 and helps doctors confirm the autoimmune nature of the disease.
Why Incidence Is Rising
Type 1 diabetes rates are increasing worldwide, and this trend can’t be explained by genetics alone, since genes don’t change that quickly across populations. Environmental shifts are the most likely explanation. Changes in childhood infections (fewer early exposures to certain microbes), alterations in gut bacteria driven by diet and antibiotic use, and other yet-unidentified factors in modern life are all suspected contributors. The increase is most pronounced in younger children and in industrialized nations, which fits with the idea that something about modern environments is pushing genetically susceptible immune systems toward autoimmunity more often than in past decades.